146 related articles for article (PubMed ID: 34000642)
21. Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma.
Sun F; Wang P; Zheng Y; Jia W; Liu F; Xiao W; Bao J; Wang S; Lu K
Oncol Lett; 2018 Jan; 15(1):489-494. PubMed ID: 29375717
[TBL] [Abstract][Full Text] [Related]
22. Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations.
Li M; Zhang L; Tang W; Duan JC; Jin YJ; Qi LL; Wu N
Cancer Imaging; 2019 Nov; 19(1):77. PubMed ID: 31783917
[TBL] [Abstract][Full Text] [Related]
23. Lymph node and bone metastasis of pulmonary intestinal adenocarcinoma: A case report.
Liu Y; Feng Z; Wei X; Yao P; Liu X; Jia Y; Zhang S; Yan W
Oncol Lett; 2023 Nov; 26(5):488. PubMed ID: 37818133
[TBL] [Abstract][Full Text] [Related]
24. Tumour Genome Characterization of a Rare Case of Pulmonary Enteric Adenocarcinoma and Prior Colon Adenocarcinoma.
Smyth RJ; Thomas V; Fay J; Ryan R; Nicholson S; Morgan RK; Grogan L; Breathnach O; Morris PG; Toomey S; Hennessy BT; Furney SJ
J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442412
[TBL] [Abstract][Full Text] [Related]
25. Clinical features and prognosis of pulmonary enteric adenocarcinoma: A retrospective study in China and the SEER database.
Wang Q; Zhang L; Li H; Liu L; Sun X; Liu H
Front Oncol; 2023; 13():1099117. PubMed ID: 37051525
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology.
Nottegar A; Tabbò F; Luchini C; Brunelli M; Bria E; Veronese N; Santo A; Cingarlini S; Gilioli E; Ogliosi C; Eccher A; Montagna L; Pedron S; Doglioni C; Cangi MG; Inghirami G; Chilosi M
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):383-387. PubMed ID: 27753661
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary enteric adenocarcinoma: an overview.
Palmirotta R; Lovero D; D'Oronzo S; Todisco A; Internò V; Mele F; Stucci LS; Silvestris F
Expert Rev Mol Med; 2020 Apr; 22():e1. PubMed ID: 32340641
[TBL] [Abstract][Full Text] [Related]
28. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
[TBL] [Abstract][Full Text] [Related]
29. Combination of Pembrolizumab With Platinum-containing Chemotherapy for Pulmonary Enteric Adenocarcinoma.
Teranishi S; Sugimoto C; Nagayama H; Segawa W; Miyasaka A; Hiro S; Maeda C; Tamura H; Masumoto N; Nagahara Y; Hirama N; Kobayashi N; Yamamoto M; Kudo M; Kaneko T
Cancer Diagn Progn; 2022; 2(2):253-257. PubMed ID: 35399182
[TBL] [Abstract][Full Text] [Related]
30. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
Ludovini V; Bianconi F; Pistola L; Chiari R; Minotti V; Colella R; Giuffrida D; Tofanetti FR; Siggillino A; Flacco A; Baldelli E; Iacono D; Mameli MG; Cavaliere A; Crinò L
J Thorac Oncol; 2011 Apr; 6(4):707-15. PubMed ID: 21258250
[TBL] [Abstract][Full Text] [Related]
31. Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutations.
Song DH; Lee B; Shin Y; Choi IH; Ha SY; Lee JJ; Hong ME; Choi YL; Han J; Um SW
Diagn Cytopathol; 2015 Jul; 43(7):539-44. PubMed ID: 25427298
[TBL] [Abstract][Full Text] [Related]
32. [Driver genes expression and clinical characteristics of targeted therapy in non-small cell lung cancer in Yunnan-Kweichow Plateau].
Lin YP; Li Q; Ma LY; Liu X; Dai M; Wang XX; Li HS; Liu JX; Shen ZH; Guo YJ; Du YX; Yang RJ; Huang YC; Zhou YC
Zhonghua Zhong Liu Za Zhi; 2020 Sep; 42(9):735-740. PubMed ID: 32988155
[No Abstract] [Full Text] [Related]
33. Primary pulmonary enteric adenocarcinoma presenting as a solitary skull mass.
D'Mello K; Cevik J; Wong DJY; Goh A; Hart C
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38238167
[TBL] [Abstract][Full Text] [Related]
34. On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas.
Mescam-Mancini L; Lantuéjoul S; Moro-Sibilot D; Rouquette I; Souquet PJ; Audigier-Valette C; Sabourin JC; Decroisette C; Sakhri L; Brambilla E; McLeer-Florin A
Lung Cancer; 2014 Feb; 83(2):168-73. PubMed ID: 24380695
[TBL] [Abstract][Full Text] [Related]
35. Anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer: a meta-analysis.
Song QB; Wang Q; Hu WG
World J Gastroenterol; 2015 Apr; 21(14):4365-72. PubMed ID: 25892888
[TBL] [Abstract][Full Text] [Related]
36. Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.
Tanaka K; Hida T; Oya Y; Yoshida T; Shimizu J; Mizuno T; Kuroda H; Sakakura N; Yoshimura K; Horio Y; Sakao Y; Yatabe Y
Cancer; 2017 May; 123(10):1731-1740. PubMed ID: 28177518
[TBL] [Abstract][Full Text] [Related]
37. Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma.
Yuan XH; Yang J; Wang XY; Zhang XL; Qin TT; Li K
Oncol Lett; 2018 Aug; 16(2):2105-2112. PubMed ID: 30008907
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy-guided bronchoscopy.
Sánchez-Font A; Chalela R; Martín-Ontiyuelo C; Albero-González R; Dalmases A; Longarón R; Alonso-Espinaco V; Curull V; Bellosillo B; Pijuan L
Cancer Cytopathol; 2018 Oct; 126(10):860-871. PubMed ID: 30291816
[TBL] [Abstract][Full Text] [Related]
39. Lung adenocarcinomas with HER2-activating mutations are associated with distinct clinical features and HER2/EGFR copy number gains.
Li C; Sun Y; Fang R; Han X; Luo X; Wang R; Pan Y; Hu H; Zhang Y; Pao W; Shen L; Ji H; Chen H
J Thorac Oncol; 2012 Jan; 7(1):85-9. PubMed ID: 22071781
[TBL] [Abstract][Full Text] [Related]
40. EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients.
Créquit P; Ruppert AM; Rozensztajn N; Gounant V; Vieira T; Poulot V; Antoine M; Chouaid C; Wislez M; Cadranel J; Lavole A
Lung Cancer; 2016 Jun; 96():74-7. PubMed ID: 27133754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
